Segmental citrate anticoagulation for double‑filtration plasmapheresis: A case report and literature review
Authors:
Open Access
- 31 May 2022
- journal article
- research article
- Published by Spandidos Publications in Medicine International
- Vol. 2 (3) , 1-7
Abstract
Regional citrate anticoagulation (RCA) has been widely used in patients with high‑risk bleeding for anticoagulation in renal replacement therapy. However, scientific reports on the use of RCA in double‑filtration plasmapheresis (DFPP) are limited. In the available reports, anticoagulation was not performed in the plasma component separator. However, as demonstrated in the present study, during the treatment of a patient with anti‑neutrophil cytoplasmic antibody‑associated vasculitis, although RCA was used for DFPP, coagulation occurred in the plasma component separator, resulting in the interruption of treatment. Thus, segmental citrate anticoagulation (SCA) was used and the filter was successfully prevented from clotting again. The present study demonstrates that SCA can more effectively prevent the clogging of the plasma separator and the plasma component separator, thereby maintaining the continuity of treatment and avoiding treatment interruption.Keywords
This publication has 24 references indexed in Scilit:
- Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trialCritical Care, 2015
- Citrate Pharmacokinetics in Critically Ill Patients with Acute Kidney InjuryPLOS ONE, 2013
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- A Target-Orientated Algorithm for Regional Citrate-Calcium Anticoagulation in Extracorporeal TherapiesBlood Purification, 2011
- Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysisAmerican Journal of Kidney Diseases, 2011
- Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot studyActa Anaesthesiologica Scandinavica, 2010
- Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal VasculitisJournal of the American Society of Nephrology, 2007
- Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulationIntensive Care Medicine, 1995
- Citrate Anticoagulation and Divalent Cations in HemodialysisBlood Purification, 1994
- The American College of Rheumatology 1990 criteria for the classification of vasculitis: Patients and methodsArthritis & Rheumatism, 1990